Literature DB >> 23220812

Effectiveness of dry needling for the treatment of temporomandibular myofascial pain: a double-blind, randomized, placebo controlled study.

Demirhan Dıraçoğlu1, Meltem Vural, Ayşe Karan, Cihan Aksoy.   

Abstract

BACKGROUND AND OBJECTIVES: To test the hypothesis that dry needling is more effective than sham dry needling in relieving myofascial pain of the temporomandibular muscles. MATERIAL AND
METHOD: Fifty-two subjects with established myofascial trigger points were randomized into two groups; study group (N: 26) and placebo group (N: 26). Dry needling was applied using acupuncture needles. Sham dry needling was applied to the placebo group. Pain pressure threshold was measured with pressure algometry, pain intensity was rated using a 10-cm visual analog scale (VAS) and the unassisted jaw opening without pain measurement was performed. Evaluations were done by a physician blinded to the data.
RESULTS: Of 52 patients assigned, 50 completed the study. Mean algometric values were significantly higher in the study group when compared to the placebo group (p values being less than 0.05). There were no differences between the two groups in terms of VAS and unassisted jaw-opening without pain values.
CONCLUSION: Dry needling appears to be an effective treatment method in relieving the pain and tenderness of myofascial trigger points.

Entities:  

Mesh:

Year:  2012        PMID: 23220812     DOI: 10.3233/BMR-2012-0338

Source DB:  PubMed          Journal:  J Back Musculoskelet Rehabil        ISSN: 1053-8127            Impact factor:   1.398


  18 in total

1.  Trigger point dry needling: the data do not support broad applicability or robust effect.

Authors:  Kenneth Venere; Kyle Ridgeway
Journal:  J Man Manip Ther       Date:  2016-02

2.  Effectiveness of trigger point dry needling for multiple body regions: a systematic review.

Authors:  Robert Boyles; Rebecca Fowler; Derek Ramsey; Erin Burrows
Journal:  J Man Manip Ther       Date:  2015-12

Review 3.  Dry needling for management of pain in the upper quarter and craniofacial region.

Authors:  David M Kietrys; Kerstin M Palombaro; Jeffrey S Mannheimer
Journal:  Curr Pain Headache Rep       Date:  2014

4.  Spontaneous electrical activities at myofascial trigger points at different stages of recovery from injury in a rat model.

Authors:  Qiang-Min Huang; Jiao-Jiao Lv; Qiong-Mei Ruanshi; Lin Liu
Journal:  Acupunct Med       Date:  2015-05-13       Impact factor: 2.267

Review 5.  Acupuncture for musculoskeletal pain: A meta-analysis and meta-regression of sham-controlled randomized clinical trials.

Authors:  Qi-Ling Yuan; Peng Wang; Liang Liu; Fu Sun; Yong-Song Cai; Wen-Tao Wu; Mao-Lin Ye; Jiang-Tao Ma; Bang-Bang Xu; Yin-Gang Zhang
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

6.  ADVERSE EVENTS ASSOCIATED WITH THERAPEUTIC DRY NEEDLING.

Authors:  David Boyce; Hannah Wempe; Courtney Campbell; Spencer Fuehne; Edo Zylstra; Grant Smith; Christopher Wingard; Richard Jones
Journal:  Int J Sports Phys Ther       Date:  2020-02

7.  Dry needling has lasting analgesic effect in shoulder pain: a double-blind, sham-controlled trial.

Authors:  Marcus Yu Bin Pai; Juliana Takiguti Toma; Helena Hideko Seguchi Kaziyama; Clarice Listik; Ricardo Galhardoni; Lin Tchia Yeng; Manoel Jacobsen Teixeira; Daniel Ciampi de Andrade
Journal:  Pain Rep       Date:  2021-06-28

8.  Electroacupuncture for moderate and severe benign prostatic hyperplasia: a randomized controlled trial.

Authors:  Yang Wang; Baoyan Liu; Jinna Yu; Jiani Wu; Jing Wang; Zhishun Liu
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

9.  Electroacupuncture at points Baliao and Huiyang (BL35) for post-stroke detrusor overactivity.

Authors:  Yan Liu; Luran Liu; Xiaomin Wang
Journal:  Neural Regen Res       Date:  2013-06-25       Impact factor: 5.135

10.  Impact of Needle Diameter on Long-Term Dry Needling Treatment of Chronic Lumbar Myofascial Pain Syndrome.

Authors:  Gang Wang; Qian Gao; Jun Li; Yuling Tian; Jingshan Hou
Journal:  Am J Phys Med Rehabil       Date:  2016-07       Impact factor: 2.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.